Global reinsurers’ appetite for pension fund longevity risk is increasing rapidly leading to an increasing number of deals being done that transfer risk into this sector, according to Aon Hewitt, the adviser on the most recent transaction.
The rest of this article is locked. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, and all the other content. Please use this link and follow the steps.
To take out a free two week trial, use the same link but select the 'trial' option in the dropdown box.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Elliot at email@example.com
Reinsurers, longevity risk, Aon Hewitt, AstraZeneca